Gilead Acquires CymaBay: Liver Cure Leap?by Mark Eisenberg 12.02.2024Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Abacus Life Offers $25M Notes, Secure Top Market Spotby Mark Eisenberg 12.02.2024Abacus Life has announced the pricing of a $25 million public offering to refinance debt. With strong financial growth, the ...
Piper Sandler Bullish on Cass Post-Earnings Surgeby Mark Eisenberg 12.02.2024Investment firm Piper Sandler has upgraded Cass Information Systems' rating to Overweight and increased its price target. Analysts are optimistic ...
TOP Financial’s Rollercoaster: Surge to Slide Volatilityby Terry Bingman 12.02.2024Shares of TOP Financial Group Ltd. tumbled 12.2% in premarket trading today after a surge on Friday. The stock's volatility ...
Rail Vision’s Revolutionary AI Enhancing Railway Safetyby Lilu Anderson 12.02.2024Rail Vision has unveiled its next-generation AI-based computer, aimed at enhancing railway safety and preventing accidents by detecting potential hazards. ...
Jefferies Upgrades Lincoln National: Turnaround Ahead?by Terry Bingman 12.02.2024Jefferies upgrades Lincoln National to "Hold" rating, raising price target to $26.00. Upgrade based on expected RBC ratio and strategy ...
Stock Shakeups: Diamondback Energy Merger, Air Taxis in Dubai, EV Tumblesby Mark Eisenberg 12.02.2024Diamondback Energy and Endeavor Energy Resources are set to merge in a $26 billion deal, boosting Diamondback shares. Other companies ...
JPMorgan Bullish on Palmer Square Capital BDCby Mark Eisenberg 12.02.2024JPMorgan gives an optimistic outlook for Palmer Square Capital BDC, assigning it an Overweight rating and $17.00 price target. The ...
PepsiCo’s New Forecast: A Refreshing Buy Opportunity?by Mark Eisenberg 12.02.2024PepsiCo lowers organic sales growth forecast, but Citi upgrades stock rating and raises price target due to positive market expectations.
W.P. Carey Stock: Buy or Sell After Dip?by Mark Eisenberg 12.02.2024W. P. Carey & Co. faces downgrade and concerns after stock decline due to credit issues and non-renewal, but oversold ...